Annual Operating Expenses
$6.65 M
-$5.85 M-46.80%
31 December 2022
Summary:
Nymox Pharmaceutical annual total operating expenses is currently $6.65 million, with the most recent change of -$5.85 million (-46.80%) on 31 December 2022. During the last 3 years, it has fallen by -$5.07 million (-43.25%).NYMX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$1.39 M
+$3.07 M+182.15%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly total operating expenses is currently $1.39 million, with the most recent change of +$3.07 million (+182.15%) on 31 March 2023.NYMX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -43.3% | -58.0% |
| 5 y5 years | -38.4% | -45.2% |
NYMX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -67.2% | -86.1% |
Nymox Pharmaceutical Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $1.39 M(-182.1%) |
| Dec 2022 | $6.65 M(-46.8%) | -$1.69 M(-213.8%) |
| Sept 2022 | - | $1.48 M(-16.6%) |
| June 2022 | - | $1.78 M(-65.0%) |
| Mar 2022 | - | $5.07 M(+82.0%) |
| Dec 2021 | $12.50 M(+6.7%) | $2.79 M(-15.5%) |
| Sept 2021 | - | $3.30 M(-17.2%) |
| June 2021 | - | $3.98 M(+64.0%) |
| Mar 2021 | - | $2.43 M(+22.4%) |
| Dec 2020 | $11.72 M(-12.4%) | $1.98 M(-52.3%) |
| Sept 2020 | - | $4.16 M(+41.7%) |
| June 2020 | - | $2.93 M(+11.4%) |
| Mar 2020 | - | $2.63 M(-3.4%) |
| Dec 2019 | $13.38 M(+23.9%) | $2.73 M(+7.8%) |
| Sept 2019 | - | $2.53 M(-51.5%) |
| June 2019 | - | $5.22 M(+78.5%) |
| Mar 2019 | - | $2.92 M(+6.6%) |
| Dec 2018 | $10.80 M(-18.8%) | $2.74 M(-2.9%) |
| Sept 2018 | - | $2.83 M(+13.7%) |
| June 2018 | - | $2.48 M(-9.7%) |
| Mar 2018 | - | $2.75 M(-18.3%) |
| Dec 2017 | $13.31 M(+2.5%) | $3.37 M(-26.2%) |
| Sept 2017 | - | $4.57 M(+77.0%) |
| June 2017 | - | $2.58 M(-7.7%) |
| Mar 2017 | - | $2.79 M(+0.2%) |
| Dec 2016 | $12.98 M(-35.9%) | $2.79 M(-8.7%) |
| Sept 2016 | - | $3.05 M(-21.3%) |
| June 2016 | - | $3.88 M(+19.1%) |
| Mar 2016 | - | $3.26 M(-19.3%) |
| Dec 2015 | $20.26 M(+170.1%) | $4.04 M(-59.6%) |
| Sept 2015 | - | $9.99 M(+88.0%) |
| June 2015 | - | $5.31 M(+479.3%) |
| Mar 2015 | - | $917.40 K(-33.0%) |
| Dec 2014 | $7.50 M(-3.3%) | $1.37 M(-1.3%) |
| Sept 2014 | - | $1.39 M(-6.3%) |
| June 2014 | - | $1.48 M(-54.6%) |
| Mar 2014 | - | $3.26 M(+61.1%) |
| Dec 2013 | $7.76 M(-25.5%) | $2.02 M(+19.3%) |
| Sept 2013 | - | $1.70 M(-21.7%) |
| June 2013 | - | $2.17 M(+16.2%) |
| Mar 2013 | - | $1.87 M(-47.3%) |
| Dec 2012 | $10.41 M(-16.4%) | $3.54 M(+82.9%) |
| Sept 2012 | - | $1.94 M(-19.7%) |
| June 2012 | - | $2.41 M(-4.1%) |
| Mar 2012 | - | $2.52 M(+7.3%) |
| Dec 2011 | $12.45 M(+81.0%) | $2.35 M(+1.3%) |
| Sept 2011 | - | $2.31 M(-13.3%) |
| June 2011 | - | $2.67 M(-47.5%) |
| Mar 2011 | - | $5.09 M(+124.3%) |
| Dec 2010 | $6.88 M | $2.27 M(+39.0%) |
| Sept 2010 | - | $1.63 M(-1.6%) |
| June 2010 | - | $1.66 M(+25.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $1.32 M(-18.2%) |
| Dec 2009 | $5.29 M(+10.4%) | $1.62 M(+14.9%) |
| Sept 2009 | - | $1.41 M(+12.5%) |
| June 2009 | - | $1.25 M(+22.3%) |
| Mar 2009 | - | $1.02 M(+4.1%) |
| Dec 2008 | $4.80 M(-12.2%) | $982.20 K(-27.4%) |
| Sept 2008 | - | $1.35 M(+13.3%) |
| June 2008 | - | $1.19 M(-5.8%) |
| Mar 2008 | - | $1.27 M(-7.6%) |
| Dec 2007 | $5.46 M(+8.5%) | $1.37 M(-2.2%) |
| Sept 2007 | - | $1.40 M(-6.4%) |
| June 2007 | - | $1.50 M(+26.7%) |
| Mar 2007 | - | $1.18 M(-5.2%) |
| Dec 2006 | $5.04 M(+33.9%) | $1.25 M(-3.6%) |
| Sept 2006 | - | $1.29 M(-9.2%) |
| June 2006 | - | $1.43 M(+33.4%) |
| Mar 2006 | - | $1.07 M(+25.1%) |
| Dec 2005 | $3.76 M(+0.2%) | $854.00 K(-15.1%) |
| Sept 2005 | - | $1.01 M(+11.6%) |
| June 2005 | - | $901.30 K(-10.0%) |
| Mar 2005 | - | $1.00 M(+11.0%) |
| Dec 2004 | $3.75 M(-14.5%) | $902.60 K(+26.9%) |
| Sept 2004 | - | $711.50 K(-39.0%) |
| June 2004 | - | $1.17 M(+19.9%) |
| Mar 2004 | - | $973.30 K(-32.6%) |
| Dec 2003 | $4.39 M(+23.4%) | $1.45 M(+68.2%) |
| Sept 2003 | - | $859.00 K(-25.5%) |
| June 2003 | - | $1.15 M(+23.4%) |
| Mar 2003 | - | $934.50 K(+6.9%) |
| Dec 2002 | $3.55 M(+7.9%) | $874.20 K(+5.1%) |
| Sept 2002 | - | $831.80 K(-11.7%) |
| June 2002 | - | $941.90 K(+4.3%) |
| Mar 2002 | - | $903.30 K(-1.5%) |
| Dec 2001 | $3.29 M(-20.6%) | $917.50 K(+7.9%) |
| Sept 2001 | - | $850.50 K(-2.4%) |
| June 2001 | - | $871.50 K(+34.6%) |
| Mar 2001 | - | $647.60 K(-33.1%) |
| Dec 2000 | $4.15 M(+20.5%) | $967.70 K(-1.7%) |
| Sept 2000 | - | $984.40 K(-25.5%) |
| June 2000 | - | $1.32 M(+55.4%) |
| Mar 2000 | - | $850.10 K(-9.9%) |
| Dec 1999 | $3.44 M(-30.8%) | $944.00 K(-5.5%) |
| Sept 1999 | - | $999.20 K(+100.8%) |
| June 1999 | - | $497.50 K(-54.8%) |
| Mar 1999 | - | $1.10 M(-19.6%) |
| Dec 1998 | $4.98 M(+42.3%) | $1.37 M(+5.0%) |
| Sept 1998 | - | $1.30 M(+18.4%) |
| June 1998 | - | $1.10 M(-8.2%) |
| Mar 1998 | - | $1.20 M(+100.8%) |
| Dec 1997 | $3.50 M | $597.30 K(-40.3%) |
| Sept 1997 | - | $999.70 K(+11.1%) |
| June 1997 | - | $899.80 K |
FAQ
- What is Nymox Pharmaceutical annual total operating expenses?
- What is the all time high annual operating expenses for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual total operating expenses?
The current annual operating expenses of NYMX is $6.65 M
What is the all time high annual operating expenses for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual total operating expenses is $20.26 M
What is Nymox Pharmaceutical quarterly total operating expenses?
The current quarterly operating expenses of NYMX is $1.39 M
What is the all time high quarterly operating expenses for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly total operating expenses is $9.99 M